Medicure Inc SEC filings MCUJF
Medicure Inc has 481 filings in SEC EDGAR's recent list, going back to Oct 29, 2002. Its latest annual report, Form 20-F, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 19, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-X | Filing | Nov 14, 2019 | — |
| S-8 | Employee stock plan registration | Oct 9, 2007 | — |
| F-10/A | Amendmend no. 2 to the registration statement | Jan 5, 2007 | — |
| F-10/A | Filing | Jan 3, 2007 | — |
| F-X | Filing | Dec 29, 2006 | — |
| F-10 | Filing | Dec 29, 2006 | — |
| F-10/A | Amendment no. 1 to registration statement | May 24, 2006 | — |
| F-X | Form f-x | May 15, 2006 | — |
| F-10 | Registration statement | May 15, 2006 | — |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MCUJF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Manitoba, Canada
- Headquarters
- Winnipeg
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1133519
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.